VISTA controls T cell activation through nonredundant functions distinct from the PD-1/PD-L1 pathway, and the combination of anti-VISTA and anti-PD-L1 synergize to promote anti-tumor immunity in the CT26 mouse colon tumor model5. The gene discussed is VSIR; the disease is neoplasm.